4,4'-diisothiocyanostilbene-2,2'-disulfonic acid has been researched along with Glycogen Storage Disease Type I in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bánhegyi, G; Benedetti, A; Burger, HJ; Capecchi, PL; Fulceri, R; Kardon, T; Leuzzi, R; Marcolongo, P | 1 |
1 other study(ies) available for 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and Glycogen Storage Disease Type I
Article | Year |
---|---|
Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Antioxidants; Apoptosis; Biological Transport; Cell Differentiation; Cyclohexanecarboxylic Acids; Enzyme Inhibitors; Ethylmaleimide; Glucose-6-Phosphate; Glycogen Storage Disease Type I; HL-60 Cells; Humans; Microsomes; NADPH Oxidases; Neutrophils | 2003 |